Skip to main content
. 2016 Mar 1;33(2):144–151. doi: 10.5152/balkanmedj.2016.161110

FIG. 5.

FIG. 5.

The inhibitory effects of 300 μM cisplatin and/or NIM (nimodipin, 1 μM) & 3NIM (nimodipine, 3 μM), MK–801 (1 μM) & 3MK-801 (MK–801, 3 μM) and TH (thapsigargin, 100 nM) & 3TH (thapsigargin 300 nM) on DRG

(***: p<0.001 compared with the C300 group; +++: p<0.001 compared with the nimodipine group)